The treatment of XXXX .

@entity1 @entity1568 @entity242 @entity5 @entity2967 @entity80 @entity84 @entity81
Forty-four @entity1 with @entity80 were treated with curettage with or without bone grafting, and in 26 (59%) recurrence developed. Of 11 @entity1 treated with radiation, in only 1 (9%) the disease was not controlled. In 1 @entity1 , radiation-induced @entity242 developed. Since the introduction of cryosurgery 27 years ago, 51 @entity1 have been treated with cryosurgery. The @entity1 had an average age of 13 years (range, 2-32 years). Thirty-four primary @entity80 and 17 secondary @entity80 occurred in association with 7 @entity2967 , 5 @entity84 , 2 @entity81 , 2 nonossifying @entity81 , and 1 unicameral bone cyst. The @entity5 were classified as inactive in 9 @entity1 , active in 31, and aggressive in 11. Treatment consisted of local intralesional excision followed by application of liquid @entity1568 . The defect was either allowed to heal spontaneously (n = 26) or was reconstructed using an intramedullary rod (n = 2), bone grafts (n = 5), fibular strut grafts (n = 14), or polymethylmethacrylate with Steinmann pins (n = 4). At median followup of 85 months (range, 24-311 months), the overall cure rate was 82%. This was increased to 96% after a second, or repeat, cryosurgery. The disease in all @entity1 eventually was controlled by cryosurgery. The mean functional rating was 90% (range, 63%-100%). Intralesional excision with adjunctive cryosurgery is an effective method for the treatment of @entity80 .
